In the last decade, especially from 2019 to 2023, owing to the demonstration of the extensive role of ABH5 in the progression of various types of cancer, this enzyme has become quite popular among scientists as a target for the creation of inhibitors [171,172]. The gene discussed is ALKBH5; the disease is cancer.